Krsnaa Diagnostics Limited (NSE: KRSNAA)
India
· Delayed Price · Currency is INR 866.95
-7.10 (-0.81%)
Dec 26, 2024, 3:29 PM IST
Krsnaa Diagnostics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2017 |
| Revenue | 6,812 | 6,196 | 4,871 | 4,555 | 3,965 | 2,584 | Upgrade
|
| Revenue Growth (YoY) | 24.68% | 27.20% | 6.95% | 14.88% | 53.41% | 23.51% | Upgrade
|
| Cost of Revenue | 1,755 | 1,513 | 899.54 | 755.7 | 949.21 | 382.58 | Upgrade
|
| Gross Profit | 5,057 | 4,683 | 3,972 | 3,799 | 3,015 | 2,202 | Upgrade
|
| Selling, General & Admin | 1,997 | 1,888 | 1,680 | 1,724 | 1,464 | 1,060 | Upgrade
|
| Other Operating Expenses | 1,329 | 1,353 | 1,062 | 757.77 | 607.91 | 513.18 | Upgrade
|
| Operating Expenses | 4,156 | 3,987 | 3,279 | 2,895 | 2,447 | 1,898 | Upgrade
|
| Operating Income | 900.91 | 696.44 | 692.39 | 903.37 | 568.78 | 304.11 | Upgrade
|
| Interest Expense | -207.68 | -140.87 | -64.35 | -168.63 | -249.27 | -231.87 | Upgrade
|
| Interest & Investment Income | 167.6 | 167.6 | 181.24 | 149.09 | 122.25 | 118.23 | Upgrade
|
| Other Non Operating Income (Expenses) | 11.63 | -23.67 | -9.03 | -16.27 | -10.02 | -3.48 | Upgrade
|
| EBT Excluding Unusual Items | 872.46 | 699.5 | 800.25 | 867.56 | 431.74 | 186.99 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.57 | 0.57 | 1.76 | -2.48 | -5.06 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 2,528 | -1,770 | Upgrade
|
| Pretax Income | 873.03 | 700.07 | 802.01 | 865.08 | 2,955 | -1,583 | Upgrade
|
| Income Tax Expense | 180.88 | 131.7 | 180.9 | 181.2 | 1,105 | -463.81 | Upgrade
|
| Net Income | 692.15 | 568.37 | 621.11 | 683.88 | 1,849 | -1,120 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 0.57 | Upgrade
|
| Net Income to Common | 692.15 | 568.37 | 621.11 | 683.88 | 1,849 | -1,120 | Upgrade
|
| Net Income Growth | 19.96% | -8.49% | -9.18% | -63.02% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 32 | 32 | 31 | 30 | 12 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 32 | 30 | 26 | 10 | Upgrade
|
| Shares Change (YoY) | 2.27% | 1.99% | 7.74% | 16.13% | 149.21% | 0.02% | Upgrade
|
| EPS (Basic) | 21.50 | 17.90 | 19.78 | 22.89 | 160.36 | -108.47 | Upgrade
|
| EPS (Diluted) | 20.94 | 17.31 | 19.29 | 22.88 | 12.25 | -108.47 | Upgrade
|
| EPS Growth | 17.31% | -10.26% | -15.69% | 86.72% | - | - | Upgrade
|
| Free Cash Flow | -1,147 | -1,695 | -650.59 | -37.95 | 357.18 | -389.4 | Upgrade
|
| Free Cash Flow Per Share | -34.68 | -51.63 | -20.21 | -1.27 | 13.88 | -37.71 | Upgrade
|
| Dividend Per Share | - | 2.500 | 2.750 | 2.500 | - | - | Upgrade
|
| Dividend Growth | - | -9.09% | 10.00% | - | - | - | Upgrade
|
| Gross Margin | 74.24% | 75.58% | 81.53% | 83.41% | 76.06% | 85.20% | Upgrade
|
| Operating Margin | 13.23% | 11.24% | 14.21% | 19.83% | 14.35% | 11.77% | Upgrade
|
| Profit Margin | 10.16% | 9.17% | 12.75% | 15.02% | 46.65% | -43.34% | Upgrade
|
| Free Cash Flow Margin | -16.83% | -27.36% | -13.36% | -0.83% | 9.01% | -15.07% | Upgrade
|
| EBITDA | 1,654 | 1,365 | 1,220 | 1,312 | 929.6 | 620.75 | Upgrade
|
| EBITDA Margin | 24.28% | 22.02% | 25.04% | 28.81% | 23.45% | 24.02% | Upgrade
|
| D&A For EBITDA | 752.75 | 668.07 | 527.33 | 408.85 | 360.82 | 316.64 | Upgrade
|
| EBIT | 900.91 | 696.44 | 692.39 | 903.37 | 568.78 | 304.11 | Upgrade
|
| EBIT Margin | 13.23% | 11.24% | 14.21% | 19.83% | 14.35% | 11.77% | Upgrade
|
| Effective Tax Rate | 20.72% | 18.81% | 22.56% | 20.95% | 37.41% | - | Upgrade
|
| Revenue as Reported | 7,015 | 6,364 | 5,065 | 4,704 | 6,615 | 2,714 | Upgrade
|
| Advertising Expenses | - | 29.36 | 31.91 | 18.09 | 10.33 | 12.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.